Mouse RAGE variant 4 is a dominant membrane receptor that does not shed to generate soluble RAGE

Yunqian Peng, Naftali Horwitz, Edward Lakatta, Li Lin

Research output: Contribution to journalArticle

Abstract

The receptor for advanced glycation end products (RAGE) is a multi-ligand, immunoglobu-lin-like receptor that has been implicated in aging-associated diseases. Recent studies have demonstrated that both human and murine Ager genes undergo extensive alternative splicing that generates multiple putative transcripts encoding different receptor isoforms. Except for the soluble isoform (esRAGE), the majority of putative RAGE isoforms remain unstudied. Profiling of m urine Ager transcripts showed that variant transcript 4 (mRA-GE-v4), the second most abundant transcript in lungs and multiple other tissues, encodes a receptor that lacks nine residues located within the C2 extracellular section close to the trans-membrane domain. We therefore characterized mRAGEV4 isoreceptor in comparison with the full-length mRAGE (mRAGEFL). Although differing in only nine residues, mRA-GEFL and mRAGEV4 display very different cellular behaviors. While mRAGEFL undergoes constitutive, extensive shedding in the cell to generate sRAGE, mRAGEV4 hardly sheds. In addition, we found that while mRAGEFL can localize to both the plasma membrane and the endosome, mRAGEV4 is exclusively localized to the plasma membrane. These very different cellular localization patterns suggest that, in addition to their roles in sRAGE production, mRAGEFL and mRAGEV4 may play distinct, spatiotemporal roles in signaling and innate immune responses. Compared to mice, humans do not have the v4 transcript. Although hRAGE, like mRAGEFL, also localizes to the plasma membrane and the endosome, its rate of constitutive shedding is significantly lower. These observations provide valuable information regarding RAGE biology, and serve as a reference by which to create mouse models relating to human diseases.

Original languageEnglish (US)
Article numbere0153657
JournalPLoS One
Volume11
Issue number9
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Cell membranes
Protein Isoforms
Endosomes
Cell Membrane
Membranes
receptors
mice
endosomes
plasma membrane
Alternative Splicing
Innate Immunity
Genes
Aging of materials
Urine
Tissue
Ligands
Lung
alternative splicing
human diseases
Advanced Glycosylation End Product-Specific Receptor

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Mouse RAGE variant 4 is a dominant membrane receptor that does not shed to generate soluble RAGE. / Peng, Yunqian; Horwitz, Naftali; Lakatta, Edward; Lin, Li.

In: PLoS One, Vol. 11, No. 9, e0153657, 01.09.2016.

Research output: Contribution to journalArticle

@article{fbfce433ca7443ee841c6d8086958d38,
title = "Mouse RAGE variant 4 is a dominant membrane receptor that does not shed to generate soluble RAGE",
abstract = "The receptor for advanced glycation end products (RAGE) is a multi-ligand, immunoglobu-lin-like receptor that has been implicated in aging-associated diseases. Recent studies have demonstrated that both human and murine Ager genes undergo extensive alternative splicing that generates multiple putative transcripts encoding different receptor isoforms. Except for the soluble isoform (esRAGE), the majority of putative RAGE isoforms remain unstudied. Profiling of m urine Ager transcripts showed that variant transcript 4 (mRA-GE-v4), the second most abundant transcript in lungs and multiple other tissues, encodes a receptor that lacks nine residues located within the C2 extracellular section close to the trans-membrane domain. We therefore characterized mRAGEV4 isoreceptor in comparison with the full-length mRAGE (mRAGEFL). Although differing in only nine residues, mRA-GEFL and mRAGEV4 display very different cellular behaviors. While mRAGEFL undergoes constitutive, extensive shedding in the cell to generate sRAGE, mRAGEV4 hardly sheds. In addition, we found that while mRAGEFL can localize to both the plasma membrane and the endosome, mRAGEV4 is exclusively localized to the plasma membrane. These very different cellular localization patterns suggest that, in addition to their roles in sRAGE production, mRAGEFL and mRAGEV4 may play distinct, spatiotemporal roles in signaling and innate immune responses. Compared to mice, humans do not have the v4 transcript. Although hRAGE, like mRAGEFL, also localizes to the plasma membrane and the endosome, its rate of constitutive shedding is significantly lower. These observations provide valuable information regarding RAGE biology, and serve as a reference by which to create mouse models relating to human diseases.",
author = "Yunqian Peng and Naftali Horwitz and Edward Lakatta and Li Lin",
year = "2016",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0153657",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Mouse RAGE variant 4 is a dominant membrane receptor that does not shed to generate soluble RAGE

AU - Peng, Yunqian

AU - Horwitz, Naftali

AU - Lakatta, Edward

AU - Lin, Li

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The receptor for advanced glycation end products (RAGE) is a multi-ligand, immunoglobu-lin-like receptor that has been implicated in aging-associated diseases. Recent studies have demonstrated that both human and murine Ager genes undergo extensive alternative splicing that generates multiple putative transcripts encoding different receptor isoforms. Except for the soluble isoform (esRAGE), the majority of putative RAGE isoforms remain unstudied. Profiling of m urine Ager transcripts showed that variant transcript 4 (mRA-GE-v4), the second most abundant transcript in lungs and multiple other tissues, encodes a receptor that lacks nine residues located within the C2 extracellular section close to the trans-membrane domain. We therefore characterized mRAGEV4 isoreceptor in comparison with the full-length mRAGE (mRAGEFL). Although differing in only nine residues, mRA-GEFL and mRAGEV4 display very different cellular behaviors. While mRAGEFL undergoes constitutive, extensive shedding in the cell to generate sRAGE, mRAGEV4 hardly sheds. In addition, we found that while mRAGEFL can localize to both the plasma membrane and the endosome, mRAGEV4 is exclusively localized to the plasma membrane. These very different cellular localization patterns suggest that, in addition to their roles in sRAGE production, mRAGEFL and mRAGEV4 may play distinct, spatiotemporal roles in signaling and innate immune responses. Compared to mice, humans do not have the v4 transcript. Although hRAGE, like mRAGEFL, also localizes to the plasma membrane and the endosome, its rate of constitutive shedding is significantly lower. These observations provide valuable information regarding RAGE biology, and serve as a reference by which to create mouse models relating to human diseases.

AB - The receptor for advanced glycation end products (RAGE) is a multi-ligand, immunoglobu-lin-like receptor that has been implicated in aging-associated diseases. Recent studies have demonstrated that both human and murine Ager genes undergo extensive alternative splicing that generates multiple putative transcripts encoding different receptor isoforms. Except for the soluble isoform (esRAGE), the majority of putative RAGE isoforms remain unstudied. Profiling of m urine Ager transcripts showed that variant transcript 4 (mRA-GE-v4), the second most abundant transcript in lungs and multiple other tissues, encodes a receptor that lacks nine residues located within the C2 extracellular section close to the trans-membrane domain. We therefore characterized mRAGEV4 isoreceptor in comparison with the full-length mRAGE (mRAGEFL). Although differing in only nine residues, mRA-GEFL and mRAGEV4 display very different cellular behaviors. While mRAGEFL undergoes constitutive, extensive shedding in the cell to generate sRAGE, mRAGEV4 hardly sheds. In addition, we found that while mRAGEFL can localize to both the plasma membrane and the endosome, mRAGEV4 is exclusively localized to the plasma membrane. These very different cellular localization patterns suggest that, in addition to their roles in sRAGE production, mRAGEFL and mRAGEV4 may play distinct, spatiotemporal roles in signaling and innate immune responses. Compared to mice, humans do not have the v4 transcript. Although hRAGE, like mRAGEFL, also localizes to the plasma membrane and the endosome, its rate of constitutive shedding is significantly lower. These observations provide valuable information regarding RAGE biology, and serve as a reference by which to create mouse models relating to human diseases.

UR - http://www.scopus.com/inward/record.url?scp=84992223539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992223539&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0153657

DO - 10.1371/journal.pone.0153657

M3 - Article

C2 - 27655067

AN - SCOPUS:84992223539

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0153657

ER -